Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Exploratory Study of Mavrilimumab versus Anti-TNF in Rheumatoid Arthritis
2011-005649-10Phase 2Completed
- Sponsor
- MedImmune
- Start
- Jul 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of mavrilimumab in rheumatoid arthritis (RA), sponsored by MedImmune. Started Jul 2012; status: completed.
02
Drugs
mavrilimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-005649-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005649-10.